Netherlands Cancer Institute
Also known as: Antonius Ziekenhuis | Antoni van Leeuwenhoek | Antoni van Leeuwenhoek, Amsterdam | Antoni van Leeuwenhoek Hospital | Antoni van Leeuwenhoek/The Netherland Cancer Institute | Antoni van leeuwenhoek ziekenhuis | Antoni van Leeuwenhoekziekenhuis (NKI-AVL) | AVL-NKI | Comprehensive Cancer Centre The Netherlands | Medical oncologist/researcher | National Cancer Institute-Antoni van Leuwenhoek Hospital | Nehterlands cancer institute | Netherlands Cancer Institute, Amsterdam, the Netherlands | Netherlands Cancer Institute - Antoni van Leeuwenhoek | Netherlands Comprehensive Cancer Organisation (IKNL) | The Netherlands Cancer Institute | The Netherlands Cancer Institute Amsterdam | The Netherlands Cancer Institute, Amsterdam, Netherlands | The Netherlands Cancer Institute, Amsterdam, The Netherlands | The Netherlands Cancer Institute-Antoni van Leeuwenhoek | The Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis | The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1999Last known activity
Sep 17, 2025
Timeline
1910s
- Jan 1, 1913
Netherlands Cancer Institute— Founded
Drugs by trial phase (146 distinct, 166 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (69 own, 0 via acquisition)
Phase 2 (54 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Bronchogenic
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiotoxicity
- Cocaine-Related Disorders
- Colonic Neoplasms
- Colorectal Neoplasms
- Digestive System Neoplasms
- Endometrial Neoplasms
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Gastrointestinal Neoplasms
- Head and Neck Neoplasms
- Hemangiosarcoma
- Hodgkin Disease
- Inflammatory Breast Neoplasms
- Laryngeal Neoplasms
- Leiomyosarcoma
- Leishmaniasis
- Leishmaniasis, Visceral
- Liposarcoma
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, Follicular
- Melanoma
- Meningeal Carcinomatosis
- Mesothelioma
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplastic Cells, Circulating
- Ovarian Neoplasms
- Paget Disease, Extramammary
- Pancreatic Neoplasms
- Penile Neoplasms
- Peritoneal Neoplasms
- Prostatic Neoplasms
- Radiation Injuries
- Rectal Neoplasms
- Sarcoma
- Sarcoma, Clear Cell
- Skin Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Triple Negative Breast Neoplasms
- Uterine Cervical Neoplasms
- Uterine Neoplasms
- Vulvar Neoplasms
Recent trials (50)
- NCT07176689OfficialPhase 4Sep 17, 2025
- NCT06823479Lead sponsorPhase 2May 14, 2025
- NCT06823479OfficialPhase 2May 14, 2025
- NCT06888817OfficialPhase 3Apr 30, 2025
- NCT06888817Lead sponsorPhase 3Apr 30, 2025
- NCT06659926Lead sponsorN/ADec 1, 2024
- NCT06857773Lead sponsorPhase 3Nov 21, 2024
- NCT06353906Lead sponsorPhase 2Aug 13, 2024
- NCT06353906OfficialPhase 2Aug 13, 2024
- NCT06855095Lead sponsorPhase 2/Phase 3Jun 25, 2024
- NCT06342037Lead sponsorPhase 2Jun 12, 2024
- NCT06342037OfficialPhase 2Jun 12, 2024
- NCT06222489Lead sponsorPhase 2May 1, 2024
- NCT06222489OfficialPhase 2May 1, 2024
- NCT06364631CollaboratorPhase 3Apr 12, 2024
Details
- Founded
- Amsterdam, NL Jan 1, 1913
- Last known activity
- Sep 17, 2025